Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model

ŠEBOROVÁ, K., KOUCKÁ, K., SPALENKOVA, A., HOLÝ, P., EHRLICHOVÁ, M., SYCHRA, T., CHEN, L., BENDALE, H., OJIMA, I., SANDOVAL-ACUNA, C., TRUKSA, J., SOUČEK, P., VÁCLAVÍKOVÁ, R. Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model. Frontiers in Pharmacology. 2022, 13(NOV 9 2022), 971905. ISSN 1663-9812. E-ISSN 1663-9812. Dostupné z: doi: 10.3389/fphar.2022.971905.